Pages that link to "Q51009647"
Jump to navigation
Jump to search
The following pages link to Effects of low-dose D-serine on recognition and working memory in mice. (Q51009647):
Displaying 34 items.
- Functional alterations of astrocytes in mental disorders: pharmacological significance as a drug target (Q26798948) (← links)
- Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice. (Q27319213) (← links)
- Astrocyte-induced synaptogenesis is mediated by transforming growth factor β signaling through modulation of D-serine levels in cerebral cortex neurons (Q30460415) (← links)
- Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals (Q33990671) (← links)
- d-serine levels in Alzheimer's disease: implications for novel biomarker development (Q34475073) (← links)
- Effects of Chronic D-Serine Elevation on Animal Models of Depression and Anxiety-Related Behavior (Q34653628) (← links)
- D-cycloserine 24 and 48 hours after asphyxial cardiac arrest has no effect on hippocampal CA1 neuropathology (Q34727215) (← links)
- Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal. (Q34870758) (← links)
- Motor-Skill Learning Is Dependent on Astrocytic Activity (Q35964113) (← links)
- d-amino acid oxidase knockout (Dao(-/-) ) mice show enhanced short-term memory performance and heightened anxiety, but no sleep or circadian rhythm disruption (Q36554272) (← links)
- Searching for cognitive enhancement in the Morris water maze: better and worse performance in D-amino acid oxidase knockout (Dao(-/-)) mice. (Q36866353) (← links)
- The effect of D-serine administration on cognition and mood in older adults (Q37022036) (← links)
- D-serine increases adult hippocampal neurogenesis (Q37129606) (← links)
- Potentiation of GluN2C/D NMDA receptor subtypes in the amygdala facilitates the retention of fear and extinction learning in mice. (Q37491564) (← links)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice (Q37980657) (← links)
- D-serine and schizophrenia: an update (Q38031285) (← links)
- Deregulation of excitatory neurotransmission underlying synapse failure in Alzheimer's disease (Q38106483) (← links)
- Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia (Q38149953) (← links)
- Metabolomics reveals distinct neurochemical profiles associated with stress resilience. (Q38638954) (← links)
- Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research (Q38669576) (← links)
- Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies. (Q38699013) (← links)
- Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors (Q41603544) (← links)
- Altered cortico-striatal crosstalk underlies object recognition memory deficits in the sub-chronic phencyclidine model of schizophrenia. (Q41620673) (← links)
- Impaired D-serine-mediated cotransmission mediates cognitive dysfunction in epilepsy (Q46895041) (← links)
- Restoration of synaptic plasticity and learning in young and aged NCAM-deficient mice by enhancing neurotransmission mediated by GluN2A-containing NMDA receptors. (Q48625979) (← links)
- Potential and Challenges for the Clinical Use of d-Serine As a Cognitive Enhancer (Q49829601) (← links)
- Synaptic NMDA Receptor Activation Induces Ubiquitination and Degradation of STEP61. (Q50440080) (← links)
- Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: A randomised, double-blind, placebo-controlled trial (Q50750840) (← links)
- Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate-Type Glutamate Receptor Function (Q57177748) (← links)
- D-Serine in Neuropsychiatric Disorders: New Advances (Q59052088) (← links)
- D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression? (Q61798767) (← links)
- D-Serine Contributes to Seizure Development via ERK Signaling (Q64118703) (← links)
- d-amino Acids in Health and Disease: A Focus on Cancer (Q90231367) (← links)
- Comparative Pro-cognitive and Neurochemical Profiles of Glycine Modulatory Site Agonists and Glycine Reuptake Inhibitors in the Rat: Potential Relevance to Cognitive Dysfunction and Its Management (Q92787898) (← links)